Stay updated on Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial page.

Latest updates to the Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial page
- ChecktodayChange DetectedThe webpage has been updated to include new facility names and locations, as well as additional drug information and publications related to Hodgkin lymphoma. Notably, several locations and drug information have been removed.SummaryDifference13%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe web page has been updated to version 2.16.12, replacing the previous version 2.16.11.SummaryDifference0.0%
- Check22 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.0%
- Check29 days agoChange DetectedThe page has been updated to version v2.16.10, and the previous service alert regarding planned maintenance has been removed.SummaryDifference0.5%
- Check36 days agoChange DetectedThe web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.SummaryDifference0.1%
- Check43 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.0%
Stay in the know with updates to Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial page.